Oral drug for COVID-19 study

We are conducting a study seeking healthy males or females, between the ages of 18 to 65 years old, who have a BMI of between 18 and 32, to participate in a Covid-19 study.
The drug will be delivered orally.

This study includes :
Part 1 (cohorts 1, 3, 4,5, 6) : 3 nights, 4 days
2 follow up visits
Part 1 (cohort 2): 3 nights, 4 days + 3 nights, 4 days
2 follow up visits
Part 2: 14 nights, 15 days

If you meet the criteria for this study and would like more information, register below or call 1800 727 874.

Be a healthy male or female
Must comply with contraception requirements
Aged 18 to 65 years
Body mass index (BMI) between 18 and 30 kg/m2